Compare PTCT & VSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTCT | VSH |
|---|---|---|
| Founded | 1998 | 1962 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electrical Products |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 4.9B |
| IPO Year | 2006 | 1994 |
| Metric | PTCT | VSH |
|---|---|---|
| Price | $56.37 | $22.30 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 7 |
| Target Price | ★ $100.47 | $38.67 |
| AVG Volume (30 Days) | 939.5K | ★ 3.1M |
| Earning Date | 10-29-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 1.60% |
| EPS Growth | ★ 264.48 | 69.57 |
| EPS | 0.34 | ★ 0.63 |
| Revenue | $264,734,000.00 | ★ $3,069,048,000.00 |
| Revenue This Year | N/A | $21.51 |
| Revenue Next Year | $8.29 | $15.23 |
| P/E Ratio | $171.44 | ★ $39.78 |
| Revenue Growth | ★ 36.19 | 4.48 |
| 52 Week Low | $58.15 | $12.49 |
| 52 Week High | $90.87 | $69.47 |
| Indicator | PTCT | VSH |
|---|---|---|
| Relative Strength Index (RSI) | 33.38 | 35.86 |
| Support Level | N/A | $21.42 |
| Resistance Level | $69.74 | $30.19 |
| Average True Range (ATR) | 2.50 | 2.10 |
| MACD | -0.78 | -0.11 |
| Stochastic Oscillator | 1.01 | 9.22 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Vishay Intertechnology Inc provides a broad product portfolio of discrete semiconductors and passive electronic components to original equipment manufacturers and distributors. These products are found in industrial, computing, automotive, consumer, telecommunications, power supplies, military, aerospace, and medical markets and serve customer all over the world. Its product segments consist of two general classes: semiconductors and passive components. The company's operating segment includes metal oxide semiconductor field-effect transistors, diodes, optoelectronic components, resistors, inductors, and capacitors. Revenue mainly comes from resistors, which are basic components used in all forms of electronic circuitry to adjust and regulate levels of voltage and current.